Abstract
This study is the first to investigate potential correlations between blood groups, Rh factors, and Autism Spectrum Disorder (ASD) within a diverse dataset of 2,390 participants from multiple regions in Iraq. The participants included children with ASD, children with other neurodevelopmental disorders, typically developing children and their parents. Using chi-square tests, logistic regression analysis, and machine learning algorithms, the findings revealed that the O + blood group was the most prevalent across all groups. Importantly, logistic regression analysis identified the AB + blood group as being associated with a significantly lower risk of ASD, suggesting a novel protective factor. No significant associations were observed between other blood groups, Rh factors, and ASD risk. Additionally, the study found no statistically significant differences in blood group distributions among children with ASD, other neurodevelopmental disorders, and typically developing children. These results provide new insights into the potential immunogenetic contributions to ASD and emphasize the need for further research to confirm the protective effect of the AB + blood group. Such studies may help unravel the genetic, immunological, and environmental mechanisms underlying ASD and support the development of targeted diagnostic and preventative strategies.
Keywords: Autism spectrum disorder, Autism etiology, Blood group, Rh factor, Neurodevelopmental disorders, Immunogenetics, Protective factors
Subject terms: Genetics, Psychology, Neuroscience
Introduction
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by social communication deficits and restricted, repetitive behaviors1. Global prevalence of ASD is rising, with estimates suggesting that 1 in 36 children in the United States receive an ASD diagnosis (Centers for Disease Control and Prevention2). This necessitates extensive research into potential causes, encompassing genetic, environmental, and immunological factors3.
While significant strides have been made in understanding ASD’s genetic and environmental contributors, the potential role of blood groups and Rh factors remains underexplored, particularly in diverse populations.
Blood groups and Rh factors, determined by antigens on red blood cells, are crucial in transfusion medicine and have been implicated in various health conditions4,5. The ABO blood group system and Rh factor (positive or negative) influence susceptibility to diseases like cardiovascular diseases, infections, and autoimmune disorders. However, the potential link between blood group/Rh factor and ASD remains largely unexplored.
Emerging research suggests that immune system dysregulation, potentially influenced by genetic factors such as blood group antigens, may play a role in the neurodevelopmental processes associated with ASD6. For instance, certain blood group distributions have been associated with varying risks of neurodevelopmental disorders7. Maternal-fetal Rh incompatibility has also been explored as a potential risk factor for neurodevelopmental anomalies. Research by Yadav, Baral8 emphasizes the significant maternal and perinatal outcomes associated with Rh-negative pregnancies and the complications arising from Rh incompatibility. While their study primarily focuses on obstetric outcomes, the immunological mechanisms observed in Rh isoimmunization could provide insights into the complex etiology of neurodevelopmental disorders, including ASD.
Previous studies, such as those by Wu et al.9 and Zandi et al.10, have reported inconclusive findings regarding the association between blood groups and ASD. These studies often relied on limited datasets, lacked diversity, or did not explore the potential protective effects of specific blood groups such as AB+.
Recent studies have further investigated the potential associations between blood group incompatibilities and ASD risk. Ravi, Mendonca11 identified a significant link between Rh and ABO blood group incompatibilities and an increased risk of ASD, suggesting that maternal-fetal blood type mismatches may contribute to neurodevelopmental risks. Additionally, Geier et al.12 found a significant association between maternal Rh-negativity and an elevated risk of ASD, indicating that immune responses related to Rh incompatibility could influence neurodevelopmental vulnerabilities.
However, other studies have presented conflicting findings. Zandi et al.10 analyzed 389 case-parent trios and found no significant evidence supporting a connection between maternal-fetal blood group incompatibilities and ASD risk. Moreover, Ajdacic-Gross et al.13 identified a potential association between the AB blood group and an increased risk of neurodevelopmental disorders, though this study did not specifically focus on ASD. These findings underscore the need for further research to clarify these associations, particularly in underrepresented populations such as those in Iraq.
While the ACOG Practice Bulletin No. 19214 focuses on Rh alloimmunization management during pregnancy, it indirectly highlights the complexity of the Rh system. Studies by Croen et al.15 and Hollowood-Jones et al.16 further emphasize the multifaceted nature of ASD risk factors. Croen et al.15 found no link between maternal Rh status, thimerosal exposure, and autism risk, while Hollowood-Jones et al.16 identified metabolic differences between mothers of children with ASD and typically developing children. These studies underscore the importance of comprehensive prenatal care considering maternal and fetal health variables.
Conflicting findings exist regarding the association between blood group/Rh factor and ASD. Studies by Wu et al.9 and Zandi et al.10 highlight the need for further investigation with more extensive and diverse samples. To bridge this gap in our understanding, this study utilizes a comprehensive approach with a large and diverse sample population (2,390 samples), one of the largest ever studied in this area. By exploring potential associations between blood types and ASD risk and utilizing a large comparison group that includes children with other neurodevelopmental disorders and typically developing children, this research aims to shed light on the potential role of blood group/Rh factor in ASD etiology informing the creation of more accurate diagnostic tools or interventions.
Recent research has increasingly focused on the complex interplay of genetic, environmental, and prenatal factors in the development of ASD. Studies have suggested that pro-inflammatory events and immune system dysfunctions may play a significant role in the pathophysiology of ASD. Despite the growing body of evidence, the precise etiology of ASD remains elusive, underscoring the need for continued exploration of these contributing factors17.
The primary objective of this study is to investigate the potential correlations between blood group distribution, Rh factor, and family history with the risk of ASD. While previous research has examined these associations in various populations, there is a notable lack of studies focusing on the Iraqi population. This research aims to address this gap by leveraging a large and diverse dataset from Iraq, providing a novel perspective on the potential immunogenetic factors influencing ASD risk. Although the study does not seek to establish causality, identifying such associations could offer valuable insights that inform future research on the genetic and immunological mechanisms underlying ASD.
Objectives
The objectives of this study are:
To determine the distribution of blood groups and Rh factors among children diagnosed with ASD.
To compare the blood group and Rh factor distributions between children with ASD, children with other neurodevelopmental disorders, and typically developing children.
To investigate the correlation between the blood group and Rh factor of children with ASD and those of their parents.
To identify any significant associations between specific blood group types and the prevalence of ASD.
Hypotheses
Hypothesis 1
The distribution of blood groups and Rh factors among children diagnosed with ASD will show a higher prevalence of certain blood types than the general population.
Rationale: Descriptive statistics have indicated variations in blood group distributions among children with ASD, suggesting a distinct pattern.
Hypothesis 2
There are significant differences in the distribution of blood groups and Rh factors among children with ASD, children with other neurodevelopmental disorders, and typically developing children.
Rationale: Previous chi-square tests did not detect significant differences, but subtle variations might exist.
Hypothesis 3
There is a significant correlation between the blood group and Rh factor of children with ASD and those of their parents.
Rationale: Correlation matrices have shown potential genetic influences on blood group distributions, suggesting a possible familial pattern.
Hypothesis 4
Certain blood group types, particularly AB+, are significantly associated with a lower prevalence of ASD.
Rationale: Logistic regression analysis identified a significant association between the AB + blood group and a lower risk of ASD, indicating a potential protective effect.
Understanding the potential role of blood group and Rh factor in ASD etiology could provide new insights, potentially leading to early diagnosis, improved interventions, and the identification of biomarkers for ASD risk. We implement a comprehensive approach with a large and diverse sample population to bridge this knowledge gap.
Materials and methods
To explore the potential association between parental blood groups and ASD, this study draws on a similar methodological approach to that used by Elfeituri et al.17. In their research, a cross-sectional, descriptive-analytical study design was employed, involving the survey of parents of children diagnosed with ASD and subsequent blood group testing to identify any correlations. The data were analyzed using statistical software to accurately interpret the relationships between variables. This approach provides a useful framework for the current study, particularly regarding sample selection, data collection, and statistical analysis17.
In this study, potential risk factors for ASD are investigated by exploring correlations between blood group, Rh factor, and ASD in a sample of 2,390 participants. The dataset includes detailed information on the blood type and Rh factor of children diagnosed with ASD, their parents, and control groups comprising children with other neurodevelopmental disorders and typically developing children.
Data collection
This comprehensive dataset was collected from various governorates across Iraq, ensuring a diverse representation of participants. The data were anonymized to protect participant confidentiality. The data collection period spans from 2018 to 2024.
The data were obtained through a thorough review of clinical records maintained by the Iraqi Association for Psychotherapy. Diagnoses of ASD and other neurodevelopmental disorders were conducted by clinical psychology specialists and a psychiatrist specialized in autism at the association’s headquarters. All diagnoses followed the DSM- 5 diagnostic guidelines to ensure consistency and accuracy. Ethical approvals were obtained before data collection, adhering to international research standards.
The dataset includes the following variables:
Gender.
Age (Years).
Blood Group & Rh Factor (Child).
Blood Group & Rh Factor (Mother).
Blood Group & Rh Factor (Father).
Diagnosis (DSM- 5): All levels of ASD severity.
Governorate.
Sample groups
ASD sample
The ASD sample consists of 1,288 children diagnosed with ASD based on the criteria outlined in the DSM- 51. The sample includes children from various governorates, providing a geographically diverse representation.
Control groups
The study includes two control groups, both of which were treated statistically as control groups for comparative analysis against the ASD group:
Children with Other Neurodevelopmental Disorders: This group consists of 1,041 children diagnosed with neurodevelopmental disorders other than ASD, such as Attention-Deficit/Hyperactivity Disorder (ADHD) and specific learning disorders. This group was statistically treated as a control group to facilitate robust comparisons with the ASD group. Including this larger control group enhances the study’s statistical power and allows a better understanding of how blood group and Rh factor distributions might differ across various neurodevelopmental conditions.
Typically Developing Children: This group comprises 61 children who have not been diagnosed with any neurodevelopmental disorder. Despite its relatively smaller size, this group serves as an essential baseline for comparison to determine whether the observed blood group and Rh factor distributions are unique to neurodevelopmental conditions.
By incorporating both typically developing children and children with other neurodevelopmental disorders as control groups, the study ensures a comprehensive and statistically robust framework for analyzing differences in blood group and Rh factor distributions among children with ASD and non-ASD populations.
Gender distribution
The dataset includes 1,886 male participants (78.9%) and 504 female participants (21.1%), resulting in a male-to-female ratio of 3.74:1. This breakdown allows for investigating potential gender-related differences in blood group and Rh factor distributions.
Blood group and Rh factor distribution
The dataset includes detailed information on the blood group and Rh factor of each participant and their parents. The blood groups are categorized under the ABO system (A, B, AB, O), and the Rh factor is classified as positive (+) or negative (-). This comprehensive data allows for the investigation of potential correlations between familial blood group patterns and the prevalence of ASD.
Data imputation and preprocessing
To handle missing values in the dataset, the K-Nearest Neighbors (KNN) imputation method was used with K= 5. This technique imputes missing data by finding the five nearest neighbors in the dataset and averaging their values, ensuring that the imputed values are similar to existing data points18. Before analysis, data preprocessing steps were undertaken to ensure the quality and consistency of the dataset. These steps included encoding categorical variables, normalizing numerical data, and handling outliers to minimize their impact on the results.
Inclusion and exclusion criteria
Inclusion criteria:
Children and other participants aged 1–31 years.
Children diagnosed with ASD, other neurodevelopmental disorders, or typically developing children, with diagnoses confirmed according to the DSM- 5 diagnostic guidelines.
All ASD diagnoses were conducted by clinical psychology specialists and a psychiatrist specialized in autism at the headquarters of the Iraqi Association for Psychotherapy.
Availability of complete blood group and Rh factor data for the child and both parents.
Exclusion criteria:
Incomplete data on blood group or Rh factor for any family member.
Children with medical conditions unrelated to neurodevelopmental disorders might confound the results.
Sampling Method:
Participants were selected based on a thorough review of clinical records obtained from the Iraqi Association for Psychotherapy.
The final sample size of 2,390 participants was determined after applying the inclusion and exclusion criteria.
This selection process ensured a diverse and representative sample across various Iraqi regions.
Descriptive statistics
Descriptive statistics overview the dataset’s key characteristics, offering insights into various variables’ distribution and central tendencies. These statistics help understand the demographic composition (e.g., gender distribution, age), the prevalence of different blood groups and Rh factors, and the geographic distribution of the participants. By summarizing the data, we can identify patterns and potential areas of interest for further analysis.
Table 1 summarizes the most frequently occurring values for each categorical variable within the dataset. The focus is on highlighting the top occurrences of variables such as gender, blood group, and governorate. This table aims to provide a concise overview of the most prominent characteristics within the sample rather than detailing the complete distribution of all categories. For a comprehensive breakdown of all blood groups and Rh factors across all participant groups, refer to Table 2.
Table 1.
Summary of descriptive statistics for the dataset (n = 2390).
| Statistic | Top | Frequency | Numerical variables |
|---|---|---|---|
| Gender | Male | 1886 | - |
| Age (Years) | - | - | Mean: 7.83, SD: 3.89, Min: 1, Max: 31 |
| Blood Group & Rh Factor (Child) | O+ | 773 | - |
| Blood Group & Rh Factor (Mother) | O+ | 823 | - |
| Blood Group & Rh Factor (Father) | O+ | 934 | - |
| Diagnosis (DSM- 5) | ASD | 1288 | - |
| Governorate | Baghdad | 1666 | - |
Table 2.
Descriptive statistics for blood groups and Rh factors.
| Statistic | ASD (n = 1288) | Other Neurodevelopmental (n = 1041) | Typically Developing (n = 61) |
|---|---|---|---|
| Gender | |||
| Male | 1010 | 833 | 43 |
| Female | 278 | 208 | 18 |
| Blood Group & Rh Factor (Child) | |||
| Unique | 8 | 8 | 7 |
| Top | O+ | O+ | A+ |
| Frequency | 419 | 332 | 24 |
| Blood Group & Rh Factor (Mother) | |||
| Unique | 8 | 8 | 7 |
| Top | O+ | O+ | A+ |
| Frequency | 431 | 374 | 22 |
| Blood Group & Rh Factor (Father) | |||
| Unique | 8 | 8 | 7 |
| Top | O+ | O+ | O+ |
| Frequency | 503 | 409 | 23 |
| Governorate | |||
| Unique | 18 | 18 | 10 |
| Top | Baghdad | Baghdad | Baghdad |
| Frequency | 887 | 737 | 42 |
Note: “Unique” refers to the number of distinct categories observed for each variable within the respective groups. For example, in the case of blood group and Rh factors, it indicates the number of different blood type combinations (such as A+, O-, etc.) observed among participants in each group.
Distribution of participants by Governorate and disorder
Understanding the geographic and diagnostic distribution of participants is crucial for identifying patterns and disparities in the prevalence of ASD and other neurodevelopmental disorders across different regions. The table below (Table 3) details the number of participants from various governorates in Iraq and their corresponding diagnoses. This distribution highlights the diversity of the sample and ensures that the findings represent the broader population. By examining these distributions, we can gain insights into potential regional variations in the prevalence and diagnosis of ASD and other disorders.
Table 3.
Distribution of participants by Governorate and disorder.
| Governorate | ADHD | ASD | Communication Disorders | Intellectual Disability | Language Disorder | ODD/Oppositional Defiant Disorder | Sensory Processing Disorder - SPD | Typically Developing Children |
|---|---|---|---|---|---|---|---|---|
| Al-Anbar | 6 | 30 | 1 | 8 | 0 | 1 | 0 | 2 |
| Al-Muthanna | 0 | 12 | 0 | 1 | 0 | 0 | 0 | 0 |
| Babylon | 8 | 92 | 13 | 60 | 0 | 0 | 0 | 5 |
| Baghdad | 147 | 887 | 91 | 478 | 2 | 16 | 5 | 42 |
| Basrah | 1 | 16 | 2 | 6 | 0 | 1 | 0 | 0 |
| Diwaniyah | 1 | 20 | 6 | 4 | 0 | 0 | 0 | 1 |
| Diyala | 5 | 50 | 3 | 17 | 0 | 1 | 0 | 3 |
| Dohuk | 0 | 7 | 0 | 1 | 0 | 0 | 0 | 0 |
| Erbil | 1 | 24 | 1 | 6 | 0 | 1 | 0 | 0 |
| Karbalaa | 1 | 24 | 2 | 8 | 0 | 1 | 0 | 0 |
| Kirkuk | 5 | 10 | 0 | 5 | 0 | 0 | 0 | 0 |
| Misan | 5 | 20 | 0 | 6 | 0 | 2 | 0 | 1 |
| Mosul | 0 | 6 | 0 | 1 | 0 | 0 | 0 | 1 |
| Najaf | 0 | 17 | 1 | 7 | 0 | 1 | 0 | 2 |
| Salaheldein | 0 | 17 | 3 | 4 | 0 | 0 | 0 | 3 |
| Sulaimaniyah | 0 | 2 | 0 | 2 | 0 | 0 | 0 | 0 |
| Thiqar | 2 | 25 | 2 | 8 | 0 | 0 | 0 | 0 |
| Wasit | 3 | 29 | 1 | 3 | 0 | 0 | 0 | 1 |
This table demonstrates the distribution of participants across different governorates. It provides insights into the prevalence of various neurodevelopmental disorders, including ASD, ADHD, communication disorders, intellectual disabilities, language disorders, oppositional defiant disorder, sensory processing disorders, and the number of typically developing children. The data underscore the importance of considering regional factors when studying the prevalence and characteristics of neurodevelopmental disorders.
Statistical analysis
The data were analyzed using several statistical methods to determine the distribution of blood groups and Rh factors among the different groups (ASD, other neurodevelopmental disorders, and typically developing children):
Chi-Square Tests and Logistic Regression Analysis: These methods were used to assess the distribution of blood groups and Rh factors among the three groups and to examine the association between blood group/Rh factor and the risk of ASD, adjusting for potentially confounding variables such as age and gender. The chi-square test evaluates whether the observed distribution of categorical variables differs significantly from expected distributions, while logistic regression helps identify relationships between variables while controlling for other factors.
Effect Sizes: The odds ratios were calculated for significant results from the logistic regression analysis, providing insight into the strength and direction of the associations.
Visualization: Bar plots were created to illustrate the odds ratios for each blood group relative to the reference group (A+) and their 95% confidence intervals. This helps to understand better the impact of different blood groups on the risk of ASD.
Sensitivity Analysis: Performed to assess the robustness of the findings, including varying the parameters used in the imputation and statistical models to determine the consistency of the results.
Machine Learning Algorithms: Various machine learning algorithms were explored to predict the likelihood of ASD based on the dataset.
Data Preprocessing: Handling missing values, one-hot encoding categorical variables, and splitting the dataset into training and testing sets.
Machine Learning Models: Evaluating the performance of several models, including Logistic Regression, Decision Tree, Random Forest, Support Vector Machine (SVM), and Gradient Boosting.
Model Evaluation: Using metrics like Accuracy, Precision, Recall, F1 Score, and ROC-AUC Score to assess the effectiveness of each model.
Software and tools
SPSS software (Version 26.0; IBM Corp19). was used for data analysis and statistical tests. Data preprocessing, imputation, and machine learning models were implemented using Python libraries: Pandas for data manipulation and analysis, Scikit-learn for K-Nearest Neighbors (KNN) imputation and machine learning algorithms, Matplotlib for visualizations, and Seaborn for advanced visualizations.
Limitations
This study is characterized by a robust sample size of 2,390 individuals representing diverse regions and governorates across Iraq, which enhances the findings’ generalizability and external validity. All diagnostic assessments were conducted exclusively at the Iraqi Association for Psychotherapy headquarters, providing a controlled and standardized diagnostic environment. Evaluations were performed by a team of specialized clinical psychologists and a psychiatrist with extensive expertise in ASD. Diagnoses strictly adhered to the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM- 5), ensuring high diagnostic consistency, reliability, and accuracy.
Despite the study’s methodological rigor and strict adherence to standardized diagnostic procedures, several inherent limitations warrant acknowledgment. The clinical data collected from official records between 2018 and 2024 were obtained from reliable sources; however, external factors beyond the researchers’ control may have influenced the results.
A significant limitation is the observed variation in ASD prevalence across Iraqi governorates. Given the uniform diagnostic procedures and centralized assessments, these regional disparities are unlikely to result from inconsistencies in diagnostic resources or clinical capacity. Instead, these differences may reflect regional variations influenced by environmental, genetic, or sociocultural factors. Such factors could substantially affect the distribution of ASD cases across different areas.
It is crucial to interpret the findings with these potential influences in mind. While this study effectively minimizes biases related to diagnostic inconsistency, broader contextual factors, such as regional environmental exposures, genetic predispositions, and sociocultural dynamics, may significantly affect ASD prevalence. Future research should aim to explore these variables in greater depth, particularly through region-specific investigations that account for environmental, genetic, and sociocultural determinants, to provide a more nuanced understanding of ASD distribution across diverse populations.
Results
Descriptive statistics: blood groups and Rh factors
This section presents an overview of the distribution of blood groups and Rh factors among participants. We summarize the descriptive statistics for each participant group: children diagnosed with ASD, children with other neurodevelopmental disorders, and typically developing children (see Table 2).
The following bar chart visualizes the distribution of blood groups across three groups of children: those diagnosed with ASD, those with other neurodevelopmental disorders, and typically developing children. The x-axis lists the blood groups and Rh factors (e.g., A+, B-, O+). The y-axis represents the frequency of each blood group within each group (shown by color: yellow for ASD, orange for other neurodevelopmental disorders, and red for typically developing children) (see Fig. 1).
Fig. 1.
Distribution of Blood Groups and Rh Factors Among Children With ASD (n = 1288), Other Neurodevelopmental Disorders (n = 1041), and Typically Developing Children (n = 61).
The following key observations can be made from the data:
O + is the most frequent blood group across all participant groups.
Children with ASD have a slightly higher frequency of O + compared to the other groups.
The distribution of other blood groups (A+, B+, AB+, etc.) shows notable variations among the three groups.
These findings highlight differences in the distribution of blood groups and Rh factors, suggesting potential immunogenetic patterns associated with ASD and other neurodevelopmental conditions.
Comparative analysis of blood group and Rh factor distribution
A statistical analysis was conducted to assess whether blood group and Rh factor distributions differ across children diagnosed with ASD, other neurodevelopmental disorders, and typically developing children. The chi-square test revealed no statistically significant differences (p > 0.05), indicating similar distributions of blood types across all groups, with no clear link to neurodevelopmental disorders (Table 4).
Table 4.
Blood group and Rh factor distribution by family member (Sample Counts).
| Blood Group & Rh Factor | Sample Count (Child) | Sample Count (Mother) | Sample Count (Father) |
|---|---|---|---|
| A- | 59 | 66 | 41 |
| A+ | 640 | 598 | 582 |
| AB- | 14 | 27 | 17 |
| AB+ | 176 | 208 | 229 |
| B- | 45 | 51 | 41 |
| B+ | 604 | 523 | 477 |
| O- | 79 | 94 | 69 |
| O+ | 773 | 823 | 934 |
| Total Sample | 2390 | 2390 | 2390 |
Further analysis of blood group and Rh factor distributions among children, mothers, and fathers also showed no significant familial differences (p = 0.999), as shown in Table 5. These results suggest that familial blood group inheritance patterns are unlikely to influence the risk of neurodevelopmental disorders.
Table 5.
Chi-Square test results for blood groups & Rh factors.
| Group | Chi-Square | p-value | Degrees of Freedom |
|---|---|---|---|
| Blood Group & Rh Factor (Combined) | 28.60 | 0.999 | 56 |
While no significant associations were found, future research could explore potential interactions between genetic factors, environmental exposures, and blood group antigens that may contribute to neurodevelopmental outcomes.
Logistic regression analysis: blood group/rh factor and ASD risk
We used logistic regression to investigate the association between blood group/Rh factor and the likelihood of developing ASD in children. This analysis helps us understand how specific blood group categories are associated with ASD risk compared to a reference group (often the most frequent blood group).
Table 6 summarizes the results of the logistic regression analysis.
Table 6.
Logistic regression analysis summary.
| Variable | Coefficient | Std. Error | z-value | p > z | [95% CI] |
|---|---|---|---|---|---|
| const | 0.1985 | 0.113 | 1.759 | 0.079 | [− 0.023, 0.420] |
| Gender_Male | − 0.0607 | 0.101 | − 0.601 | 0.548 | [− 0.259, 0.137] |
| Blood Group & Rh Factor (Child)_A- | 0.2231 | 0.277 | 0.806 | 0.420 | [− 0.319, 0.765] |
| Blood Group & Rh Factor (Child)_AB+ | − 0.3555 | 0.171 | − 2.078 | 0.038** | [− 0.691, − 0.020] |
| Blood Group & Rh Factor (Child)_AB- | − 0.1595 | 0.541 | − 0.295 | 0.768 | [− 1.219, 0.900] |
| Blood Group & Rh Factor (Child)_B+ | 0.0551 | 0.114 | 0.484 | 0.629 | [− 0.168, 0.278] |
| Blood Group & Rh Factor (Child)_B- | − 0.2862 | 0.309 | − 0.926 | 0.355 | [− 0.892, 0.320] |
| Blood Group & Rh Factor (Child)_O+ | 0.0188 | 0.107 | 0.175 | 0.861 | [− 0.191, 0.229] |
| Blood Group & Rh Factor (Child)_O- | 0.3917 | 0.247 | 1.588 | 0.112 | [− 0.092, 0.875] |
Note: Bolded p-value indicates statistical significance (p < 0.05).
The logistic regression analysis indicates that most blood groups and Rh factors do not show a significant association with the risk of ASD. Children with the AB + blood group were the only exception (p = 0.038), suggesting a potentially lower risk of ASD compared to the reference group (often the most frequent blood group in the study population). The other variables, including gender and other blood groups, did not show statistically significant associations with ASD risk in this analysis.
In this logistic regression analysis, the ASD group was compared against a combined control group comprising both children with other neurodevelopmental disorders and typically developing children. This approach was adopted to enhance the statistical power of the analysis, given the relatively small size of the typically developing control group alone. By integrating both groups into the control category, the analysis ensures a more robust and representative comparison. The findings, therefore, reflect associations observed when comparing children diagnosed with ASD to a broader control population.
Effect sizes: odds ratios
Odds ratios measure the strength of association between variables in logistic regression. Here, we focus on the significant results (p-value < 0.05):
Blood Group & Rh Factor (Child) AB+: The odds ratio (0.7008) is significantly less than 1, indicating that children with the AB + blood type are less likely to have ASD than the reference group. This suggests a potentially protective effect of the AB + blood type.
The other blood group variables have odds ratios close to 1, suggesting no strong association with ASD risk (see Table 7).
Table 7.
Odds ratios from the logistic regression analysis.
| Variable | Odds Ratio | 95% Confidence Interval | p-value |
|---|---|---|---|
| Const | 1.2196 | [0.977, 1.522] | 0.079 |
| Gender_Male | 0.9411 | [0.772, 1.147] | 0.548 |
| Blood Group & Rh Factor (Child)_A- | 1.2500 | [0.727, 2.149] | 0.420 |
| Blood Group & Rh Factor (Child)_AB+ | 0.7008 | [0.501, 0.980] | 0.038* |
| Blood Group & Rh Factor (Child)_AB- | 0.8526 | [0.296, 2.459] | 0.768 |
| Blood Group & Rh Factor (Child)_B+ | 1.0567 | [0.845, 1.320] | 0.629 |
| Blood Group & Rh Factor (Child)_B- | 0.7511 | [0.410, 1.377] | 0.355 |
| Blood Group & Rh Factor (Child)_O+ | 1.0190 | [0.826, 1.257] | 0.861 |
| Blood Group & Rh Factor (Child)_O- | 1.4794 | [0.912, 2.398] | 0.112 |
* p-value < 0.05 indicates statistical significance.
Logistic regression analysis: blood group and Rh factor associations with ASD risk
A logistic regression analysis was conducted to investigate the association between blood group, Rh factor, and the likelihood of developing ASD in children. The A + blood group and Rh-positive status were used as reference categories. The results are visualized in two bar plots (Figs. 2 and 3), displaying odds ratios and corresponding 95% confidence intervals.
Fig. 2.
Odds Ratios From Logistic Regression Analysis With 95% CI.
Fig. 3.
Odds Ratios From Logistic Regression Analysis For Rh Factors.
Blood group association with ASD risk
The analysis revealed that most blood groups showed no statistically significant association with ASD risk compared to the reference group (A+). However, the AB + blood group demonstrated a significant protective effect (odds ratio = 0.7008, p = 0.038), suggesting a lower likelihood of ASD compared to children with the A + blood type. Other blood groups showed odds ratios close to 1, with confidence intervals crossing this threshold, indicating no significant differences (Fig. 2).
Rh factor association with ASD risk
An additional analysis focused on the Rh factor showed no significant association between Rh-negative status and ASD risk (odds ratio = 1.1614, p-value = 0.320). This suggests that Rh status does not significantly influence the likelihood of ASD in this sample (Fig. 3). Even after adjusting for gender, the association remained statistically insignificant.
The visual summary of the logistic regression analysis is presented in Figs. 2 and 3. Figure 2 displays the odds ratios for various blood groups relative to the A + group. The red dashed line at an odds ratio 1 signifies no association with ASD risk. Notably, the AB + blood group demonstrates a protective effect, as indicated by an odds ratio significantly below 1. Figure 3 illustrates the odds ratios for the Rh factor and gender. Although the Rh-negative status shows a slight increase in the odds of developing ASD compared to the Rh-positive group, this result is not statistically significant. Similarly, gender does not exhibit a significant association with ASD risk.
The results suggest a potential protective effect of the AB + blood group against ASD, while no significant associations were observed for other blood groups or Rh factors. Further research is needed to validate these findings and investigate the underlying biological mechanisms.
Blood group distribution and ASD risk
We investigated the distribution of blood groups among mothers and fathers of children with ASD compared to non-ASD groups using chi-square tests. Neither maternal (chi-square statistic: 7.43, p-value: 0.386) nor paternal blood groups (chi-square statistic: 2.75, p-value: 0.962) showed statistically significant differences (p > 0.05) between the groups. This suggests no significant association between parental blood group and ASD risk in children.
Logistic regression analyses for blood groups
To further explore the potential link between blood group and ASD risk, we performed logistic regression analyses for both maternal and paternal blood groups. The odds ratios from these analyses are presented in Table 8.
Table 8.
Odds ratios from logistic regression analyses for blood groups.
| Variable | Maternal Blood Group (Ref: A+) | Paternal Blood Group (Ref: A+) |
|---|---|---|
| const | 1.3492 | 1.2239 |
| Gender (Male) | 0.9433 | 0.9367 |
| Blood Group & Rh Factor (Mother/Father)_A- | 1.1905 | 1.4905 |
| Blood Group & Rh Factor (Mother/Father)_AB+ | 0.8560 | 0.9300 |
| Blood Group & Rh Factor (Mother/Father)_AB- | 0.4571 | 0.9775 |
| Blood Group & Rh Factor (Mother/Father)_B+ | 0.9159 | 1.0058 |
| Blood Group & Rh Factor (Mother/Father)_B- | 0.7432 | 0.9972 |
| Blood Group & Rh Factor (Mother/Father)_O+ | 0.9947 | 1.0042 |
| Blood Group & Rh Factor (Mother/Father)_O- | 1.3024 | 1.1201 |
The logistic regression analyses identified a marginally non-significant association between maternal blood group AB- and ASD risk (p = 0.054) (Fig. 4). This suggests a possible lower likelihood of ASD for children with mothers having blood group AB-, but further studies are needed to confirm this due to the lack of statistical significance. Other maternal blood groups did not show statistically significant associations with ASD.
Fig. 4.
Odds Ratios From Logistic Regression Analysis For Maternal Blood Groups.
For paternal blood groups, none of the blood groups showed statistically significant associations with ASD (Fig. 5). All odds ratios were close to 1, indicating no significant difference in ASD risk compared to the reference group (blood group A+) based on paternal blood type.
Fig. 5.
Odds Ratios From Logistic Regression Analysis For Paternal Blood Groups.
Principal component analysis (PCA) with effect sizes
Dimensionality reduction and logistic regression
PCA reduced the dataset to five principal components (PCs), capturing approximately 36% of the total variance. A logistic regression model using these PCs showed moderate predictive ability, with a balanced accuracy of 54.6%, precision of 56.0%, ROC-AUC of 0.500, and a high recall of 89.96%, indicating effective detection of ASD cases.
Effect sizes and associations
The model coefficients revealed mixed associations with ASD risk.
PC5 had the strongest negative effect (− 0.1073), indicating a potential protective factor.
PC3 showed a positive association (0.0579), suggesting an increased likelihood of ASD.
In Conclusion, PCA effectively simplified the data while retaining key information. Although the model’s overall predictive power was moderate, the high recall highlights its potential for detecting ASD. The principal components’ varying associations suggest complex relationships that merit further research.
Blood groups, Rh factors, and ASD relationships
This analysis explores the potential link between blood groups, Rh factors, and ASD in children. We leverage correlation matrices to visualize the strength and direction of these relationships.
The provided heatmap (Fig. 6) depicts a correlation matrix for children diagnosed with ASD. This visual representation helps us understand this group’s genetic and hereditary patterns. Warmer colors indicate a positive correlation, while cooler colors represent a negative correlation. The intensity of the color reflects the strength of the correlation.
Fig. 6.
Correlation Matrix for Blood Groups and Rh Factors in Children Diagnosed with ASD.
For example, a strong positive correlation between a specific blood group in a parent (e.g., a mother with blood group B+) and ASD in the child might suggest a potential genetic influence related to genes associated with blood group determination. Conversely, a strong negative correlation between a specific blood group combination in parents (e.g., father with O- and mother with AB+) and ASD in the child could indicate a protective effect, possibly due to immunological factors associated with Rh factor incompatibility.
Examining the baseline: correlation matrix for Non-ASD diagnoses
We have also included a correlation matrix for children with diagnoses other than ASD (Fig. 7). This serves as a baseline for comparison. By analyzing both ASD and non-ASD groups, we can identify unique patterns related to ASD and differentiate them from more general trends in the population.
Fig. 7.
Correlation Matrix for Blood Groups and Rh Factors in Children with Non-ASD Diagnoses.
The heatmaps for both groups provide a valuable tool to visually compare similarities and differences in correlation patterns. This comparative approach can shed light on potential genetic factors associated with the development of ASD.
This analysis offers a starting point for further investigation into the complex relationship between blood groups, Rh factors, and ASD. By delving deeper into these correlations, researchers may gain valuable insights into the underlying mechanisms of ASD and potentially contribute to developing improved diagnostic tools or preventative strategies.
Blood group and Rh factor prevalence by disorder
Table 9 summarizes the prevalence of blood groups among children, mothers, and fathers for various disorders.
Table 9.
Blood group prevalence by disorder.
| Disorder | Most Prevalent Child | Least Prevalent Child | Most Prevalent Mother | Least Prevalent Mother | Most Prevalent Father | Least Prevalent Father |
|---|---|---|---|---|---|---|
| ADHD | O+ | AB- | O+ | AB- | O+ | B- |
| Autism Spectrum Disorder | O+ | AB- | O+ | AB- | O+ | AB- |
| Communication Disorders | A+ | A- | O+ | AB- | O+ | AB+ |
| Intellectual Disability | O+ | AB- | O+ | AB- | O+ | AB- |
| Language Disorder | O- | O- | O- | O- | O+ | O+ |
| Oppositional Defiant Disorder | A+ | B+ | O+ | AB+ | A+ | AB+ |
| Sensory Processing Disorder – SPD | O+ | A+ | B+ | A+ | A+ | O- |
| Typically Developing | O+ | A- | A+ | B- | O+ | B- |
From Table 9, the analysis reveals a trend of O + being the most prevalent blood group among children, mothers, and fathers for many disorders (ADHD, ASD, Intellectual Disability, Sensory Processing Disorder, typically developing children). However, there are exceptions for specific disorders and family member groups (e.g., Language Disorder with O- in children and mothers). AB- is generally the least prevalent blood group, with exceptions for Language Disorder (O+) and Oppositional Defiant Disorder (AB+). These findings offer a starting point for further research into potential genetic and hereditary links between blood groups and neurodevelopmental disorders.
Blood group inheritance patterns
The heatmap visualizes the inheritance patterns of blood groups in the study participants (Fig. 8). Each cell represents the number of children who inherited a specific blood group (shown on the x-axis) based on the combination of their mother’s and father’s blood groups (represented on the y-axis). This comprehensive visualization ensures clarity by labeling all possible parental blood group combinations, allowing for accurate interpretation of inheritance patterns and a clearer understanding of the observed trends.
Fig. 8.
Blood Group Inheritance Patterns: The heatmap illustrates the distribution of child blood groups from various parental blood group combinations. Each parental blood group combination is clearly labeled, facilitating an accurate interpretation of inheritance trends and highlighting the frequency of each outcome.
To analyze the inheritance patterns of blood groups, we examined the relationships between parents and children’s blood types through a structured three-step process. First, all possible combinations of mother and father blood groups were identified. Second, each child’s blood group frequency was recorded for each parental combination. Finally, these patterns were visualized using a heatmap to provide an intuitive understanding of the inheritance dynamics.
Machine learning algorithms
In our analysis, we explored various machine learning algorithms to predict the likelihood of ASD based on our dataset. The process involved these key steps:
Data Preprocessing: We handled missing values one-hot encoded categorical variables and split the dataset into training and testing sets.
Machine Learning Models: We evaluated the performance of several models, including Logistic Regression, Decision Tree, Random Forest, Support Vector Machine (SVM), and Gradient Boosting.
Model Evaluation: We assessed each model’s effectiveness using Accuracy, Precision, Recall, F1 Score, and ROC-AUC Score metrics.
Here is a summary of our findings (see Table 10):
Table 10.
Performance metrics of various machine learning models for predicting ASD.
| Machine Learning Model | Overall Performance (Accuracy, F1 Score) | Recall | ROC-AUC |
|---|---|---|---|
| Logistic Regression | 56.3%, 0.693 | 0.877 | 0.518 |
| Decision Tree | 53.3%, 0.624 | 0.821 | 0.518 |
| Random Forest | 54.8%, 0.649 | 0.845 | 0.531 |
| Support Vector Machine (SVM) | 53.6%, 0.680 | 0.852 | 0.487 |
| Gradient Boosting | 55.2%, 0.685 | 0.868 | 0.546 |
Logistic Regression: Achieved the highest accuracy (56.3%) and F1 score (0.693), with a high recall (87.7%), indicating good detection of true positive cases. However, its ROC-AUC score (0.518) suggests limited ability to distinguish between ASD and non-ASD cases.
Decision Tree: Lower accuracy (53.3%) and F1 score (0.624) compared to Logistic Regression, with a similar ROC-AUC score (0.518).
Random Forest: Slightly better accuracy (54.8%) and F1 score (0.649) than Decision Tree, with a higher ROC-AUC score (0.531) indicating improved discrimination ability.
Support Vector Machine (SVM): Moderate accuracy (53.6%) and F1 score (0.680) but struggles with discrimination, as indicated by its low ROC-AUC score (0.487) despite high recall (87.7%).
Gradient Boosting: Achieved accuracy (55.2%) and F1 score (0.685) close to Logistic Regression, with the highest ROC-AUC score (0.546) among the models, indicating superior overall performance in distinguishing between ASD and non-ASD cases.
Conclusion: Gradient Boosting performed the best overall, showing a good balance of accuracy, recall, and the highest ROC-AUC score. Logistic Regression also performed well, especially regarding recall and F1 score.
Final findings
This analysis has comprehensively explored potential associations between blood groups, Rh factors, and ASD risk. Here is a breakdown of the key findings:
Descriptive Statistics and Distribution Analysis:
The O + blood group is the most prevalent across all participant groups.
Children with ASD show a slightly higher frequency of the O + blood type.
Chi-square tests revealed no significant differences in the distribution of blood groups among children with ASD, other neurodevelopmental disorders, and typically developing children.
Logistic Regression and Visualization of Results:
Logistic regression analysis identified the AB + blood group as having a significantly lower risk of ASD compared to the reference group (often A+). Bar plots visualizing these odds ratios effectively highlighted this difference. While other blood groups showed odds ratios close to 1, indicating no strong association with ASD risk, the analysis suggests a potential link between AB + blood type and reduced ASD risk.
Correlation Analysis and Machine Learning Algorithms:
Heatmaps provided insights into potential genetic influences by showing correlations between blood groups, Rh factors, and ASD diagnosis.
Various machine learning algorithms were tested to predict ASD likelihood, with Gradient Boosting performing the best overall performance.
The analysis suggests a potential association between the AB + blood group and lower ASD risk, while other blood groups and Rh factors do not show significant associations. Further research could provide deeper insights into these relationships, especially incorporating larger sample sizes and more diverse populations.
Additionally, while the analysis identified a trend towards a higher likelihood of ASD in children with Rh-negative blood type, this association was not statistically significant and warrants further investigation.
Discussion
Objectives and hypotheses
Objective 1
To determine the distribution of blood groups and Rh factors among children diagnosed with ASD. Our study found that the most prevalent blood group among children with ASD was O+ (419 out of 1288, approximately 32.5%). This is consistent with the distribution observed in the general population, where O + is typically the most common blood group. However, AB- was the least common, suggesting no unusual distribution patterns specific to ASD.
Objective 2
To compare the blood group and Rh factor distributions between children with ASD, other neurodevelopmental disorders, and typically developing children. The chi-square test results indicated no statistically significant difference in the distribution of blood groups across children with ASD, other neurodevelopmental disorders, and typically developing children (chi-square statistic = 65.18, p-value = 0.19). This suggests that the blood group distributions are similar among these groups, which aligns with the findings of Wu et al.9 and Zandi et al.10, who reported no significant associations between blood groups and ASD risk.
Objective 3
To investigate the correlation between the blood group and Rh factor of children with ASD and those of their parents. The logistic regression analysis revealed that most blood groups and Rh factors do not show a significant association with the risk of ASD. However, children with the AB + blood group were the exception, with a significant protective effect (odds ratio = 0.7008, p-value= 0.038). This protective effect might be attributed to the universal recipient status of the AB + blood type, which allows individuals with this blood type to receive blood from any other type without the risk of adverse immune reactions. This unique characteristic is due to the presence of both A and B antigens on red blood cells and the absence of anti-A and anti-B antibodies in the plasma, which may confer some level of immunological flexibility20,21.
Objective 4
To identify any significant associations between specific blood group types and the prevalence of ASD. Our logistic regression analysis reveals a significant association between the AB + blood group and a lower likelihood of ASD, supporting the hypothesis that certain blood group types may confer either protective or risk factors for ASD. This association aligns with previous research suggesting that immunological and genetic characteristics linked to blood groups may influence various health outcomes.
Individuals with the AB blood type express both A and B antigens on their red blood cells and lack anti-A and anti-B antibodies in their plasma22. This distinct immunological profile could contribute to a more adaptable immune response, potentially reducing systemic inflammation – a factor implicated in neurodevelopmental disruptions.
Emerging research highlights the crucial role of immune dysregulation and heightened inflammatory responses during prenatal development in the pathogenesis of ASD. Specifically, maternal immune activation (MIA) during pregnancy – often triggered by infections or environmental stressors – has been linked to alterations in fetal brain development, thereby increasing the risk of ASD23. Such immune responses may lead to neurodevelopmental disturbances that contribute to the manifestation of ASD symptoms.
Additionally, studies have consistently shown that children with ASD often exhibit elevated levels of pro-inflammatory cytokines, including interleukin- 6 (IL- 6) and tumor necrosis factor-alpha (TNF-α), indicating systemic immune activation and potential neuroinflammation24. Given that ABO blood group antigens are known to influence immune function25, it is plausible that individuals with the AB blood group – due to the absence of anti-A and anti-B antibodies – may exhibit a more balanced immune response, potentially lowering the risk of inflammation-driven neurodevelopmental disruptions.
Despite these biological considerations, there is currently no definitive evidence establishing a direct association between the AB + blood group and a reduced risk of ASD. Further research is required to determine whether specific blood groups protect immune-mediated mechanisms.
Recent studies investigating the relationship between blood group antigens and health outcomes have sparked interest in the potential influence of specific blood types on the risk of neurodevelopmental disorders such as ASD. Although direct associations between ABO blood groups and ASD remain underexplored, the immunological and genetic factors linked to these blood groups could potentially modulate ASD susceptibility.
Research has demonstrated that blood group antigens contribute to immune system regulation and inflammatory responses25. For example, individuals with the O blood type generally exhibit lower levels of von Willebrand factor (vWF) and factor VIII, which play roles in vascular and immune functions26. Given the established connection between immune dysfunction, prenatal inflammation, and ASD pathogenesis23, it is plausible that certain blood group characteristics could indirectly affect ASD risk.
Furthermore, a growing body of research suggests maternal-fetal blood group incompatibility may influence neurodevelopmental outcomes. Studies have linked Rh incompatibility between mother and fetus to an increased risk of neurodevelopmental disorders, primarily due to hemolytic disease of the fetus and newborn (HDFN) and the resulting bilirubin toxicity27. Elevated bilirubin levels in neonates have been associated with adverse neurological outcomes, including a higher risk of ASD28.
In addition, evidence indicates that children with ASD frequently exhibit increased levels of inflammatory biomarkers, such as IL- 6 and TNF-α, reflecting systemic immune activation29. Considering that ABO antigens influence immune response modulation25, variations in blood groups could plausibly affect ASD susceptibility through immune-mediated mechanisms.
Despite the validity of these biological hypotheses, current research has yet to establish a definitive link between ABO blood groups and ASD risk. Further investigation is warranted to determine whether specific blood groups confer protective or risk factors, potentially through immune-related pathways or other physiological mechanisms.
Comparison with previous studies
Our findings are consistent with prior research by Wu et al.9 and Zandi et al.10, which found no significant association between most blood groups and ASD risk. However, our study expands on these findings by identifying a potential protective effect of the AB + blood group, a result not previously emphasized. This partially aligns with Vasan et al.30, who observed differences in blood type distribution but did not highlight a specific protective blood group.
In line with the results of Miles, Takahashi31, our study found no significant relationship between Rh status, Rh immune globulin exposure, and the incidence of ASD. Their analysis of 214 families with children diagnosed with ASD indicated that maternal Rh-negative status and antepartum exposure to Rh immune globulin preserved with thimerosal did not increase ASD risk. Similarly, Elfeituri et al.17 found no significant association between parental Rh blood group and ASD occurrence. However, they noted a higher likelihood of ASD in children of parents with an O + blood type, suggesting a potential, though unclear, influence of blood group.
Interestingly, Smalley et al.32 proposed a possible connection between the ABO blood group and ASD, particularly in multiplex families with at least one affected female. Although this linkage was not statistically significant, it opens avenues for further exploration of blood group antigens as potential genetic markers associated with ASD.
These findings suggest that while blood group and Rh factors may not be significant risk factors for ASD, our study’s observed protective association with the AB + blood group highlights the need for further investigation into potential immunological or genetic mechanisms underlying this relationship.
Reconciling Chi-Square and logistic regression
While the chi-square test indicated an overall difference in Rh factor distribution across the groups (ASD, other neurodevelopmental disorders, typically developing children), the logistic regression analysis suggests this difference may not translate into a significant association between Rh factor (negative) and ASD risk. This could be due to several reasons:
Limited effect size: The chi-square test is sensitive to overall distribution differences, even if they are small. However, The logistic regression analysis focuses on the association between the Rh factor (negative) and ASD, which might have a weaker effect size that does not reach statistical significance.
Other contributing factors: The chi-square test does not identify the specific cause of the difference. Other factors within the Rh-positive category may be masking the effect of Rh-negative.
Further analysis, such as examining specific comparisons within Rh factors (positive vs. negative), might be needed to understand the observed distribution difference better.
Implications of the findings
The findings of this study offer significant implications for both research and clinical practice. The observed protective association between the AB + blood group and the risk of ASD suggests a potential immunogenetic influence that warrants further investigation. This aligns with prior research by Ravi, Mendonca11 and Geier et al.12, highlighting the potential impact of maternal-fetal Rh incompatibility and immune responses on neurodevelopmental outcomes.
These results support the hypothesis that immune system dysregulation, potentially influenced by genetic factors associated with blood group antigens, may contribute to neurodevelopmental vulnerabilities. Understanding this association could lead to identifying novel biomarkers for early detection and risk assessment of ASD.
From a clinical perspective, integrating blood group and Rh factor data into risk assessment models could aid in the early identification of individuals at higher risk for ASD. This approach could help guide preventive interventions and inform targeted healthcare strategies, especially for populations with a high prevalence of Rh incompatibility.
Future research should focus on replicating these findings in more diverse populations and investigating the underlying biological mechanisms that may drive these associations. Additionally, exploring the role of other immunogenetic factors could further enhance our understanding of ASD etiology, potentially leading to more personalized diagnostic and preventative strategies.
Global blood group patterns
Blood group patterns vary globally due to genetic, environmental, and historical factors. The ABO blood group system, comprising A, B, AB, and O, shows significant regional differences. Blood group O is the most prevalent worldwide, especially in Latin America and Africa, while blood group A is common in Europe, North America, and Australia33. Blood group B is highly prevalent in Asia, particularly in India and Central Asia, but is less common in Western Europe and the Americas34. AB is the rarest blood group globally, with slightly higher frequencies in Japan and Korea35. The Rh factor also shows variation, with Rh-positive being most common globally, particularly in Africa, Asia, and among Native Americans, whereas Rh-negative is more prevalent in Europe, notably among the Basques36. These patterns are influenced by genetics, historical migrations, natural selection, and cultural practices, impacting blood transfusion services and genetic diversity studies5.
Strengths of our research
The strengths of our research include several key aspects. First, the large sample size of 2,390 participants makes our study one of the largest in investigating the association between blood groups, Rh factors, and ASD. Second, our comprehensive data collection provides detailed information on the blood types and Rh factors of children and their parents, allowing for a thorough analysis of familial patterns. Third, the data were collected from various governorates across Iraq, ensuring a geographically diverse sample. Finally, we employed advanced statistical methods, including logistic regression and machine learning models, to explore complex relationships and identify potential protective factors.
Conclusions
This study provides new insights into the potential associations between blood groups, Rh factors, and ASD. Our findings suggest that the AB + blood group may have a protective effect against ASD, contrasting with the general distributions observed in the population. While our results align with previous studies in finding no significant associations for most blood groups, they highlight the need for further research to understand the underlying mechanisms of this protective effect.
This research underscores the importance of a comprehensive approach to studying ASD and contributes to the ongoing efforts to uncover its complex etiology. Future studies should consider incorporating diverse methodologies, exploring genetic factors related to blood groups, and investigating potential immunological mechanisms. Understanding these associations could improve diagnostic tools, early interventions, and identifying biomarkers for ASD risk.
Acknowledgements
I extend my deepest gratitude to the Iraqi Association for Psychotherapy for their invaluable support and for providing access to the comprehensive archived data that formed the foundation of this research. I sincerely thank the participants and their families, whose indirect contributions were essential in advancing our understanding of Autism Spectrum Disorder (ASD).Furthermore, I am profoundly grateful to my colleagues at the Psychological Research Center for their continuous encouragement and constructive feedback throughout the research process. This work is a testament to dedicated individuals’ collaborative efforts to enhance knowledge about ASD and its potential risk factors.
Author contributions
Adil Abdul-Rehman Siddiq Al-Salihy conceptualized the study, designed the methodology, conducted the statistical analysis and machine learning implementation, performed the literature review, wrote the main manuscript text, and prepared all figures and tables. Adil Abdul-Rehman Siddiq Al-Salihy reviewed and approved the final manuscript.
Funding
This research was conducted without specific funding or financial support from external grants, organizations, or institutions. The author relied entirely on self-funding from their academic salary.
Data availability
Availability of Data and Materials: The data supporting the findings of this study are included in the article and its supplementary materials. Raw data generated during the study are available upon reasonable request from the corresponding author.
Declarations
Consent for publication
Not applicable. No individual-level data, images, or details requiring consent for publication were used in this study.
Competing interests
The authors declare no competing interests.
Ethical approval and informed consent
This study utilized pre-existing, anonymized data obtained from the archives of the Iraqi Association for Psychotherapy. The data were originally collected following ethical guidelines, with informed consent obtained from participants or their legal guardians at the time of collection. Ethical approval for the use of these data in the present study was granted by the Scientific Committee of the Iraqi Association for Psychotherapy (IAP), ensuring compliance with the principles of the Declaration of Helsinki and applicable local regulations. Since the data were fully de-identified before analysis and collected retrospectively, no additional ethical approval or informed consent was required for this study.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5™ 5th edn (American Psychiatric Publishing, 2013). [Google Scholar]
- 2.CDC: Data & Statistics on Autism Spectrum Disorder. (2024). https://www.cdc.gov/autism/data-research/?CDC_AAref_Val=https://www.cdc.gov/ncbddd/autism/data.html Accessed May 19th 2024.
- 3.Lord, C., Elsabbagh, M., Baird, G. & Veenstra-Vanderweele, J. Autism spectrum disorder. Lancet392 (10146), 508–520. 10.1016/S0140-6736(18)31129-2 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Liumbruno, G. M. & Franchini, M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus.11 (4), 491–499. 10.2450/2013.0152-13 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Daniels, G. Human Blood Group Systems. Practical Transfusion Medicine (Wiley, 2013). [Google Scholar]
- 6.Van De Goines, P. The immune system’s role in the biology of autism. Curr. Opin. Neurol.23 (2), 111–117. 10.1097/wco.0b013e3283373514 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Dittmar, M., Kautz, C., Krüger, J., Müller, C. & Schneider, H. Blood group antigens and neurodevelopmental disorders: A comprehensive study. Neurogenetics21 (4), 273–284 (2020). [Google Scholar]
- 8.Yadav, M. & Baral, G. Maternal and perinatal outcome in Rh-Negative women. Nepal. J. Obstet. Gynecol.16 (1). 10.3126/njog.v16i1.37619 (2021).
- 9.Wu, Z. T. et al. Lack of association between parental ABO blood type and autism spectrum disorders. CNS Neurosci. Ther.18 (7), 604–605. 10.1111/j.1755-5949.2012.00342.x (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zandi, P. P. et al. Rh and ABO maternal-fetal incompatibility and risk of autism. Am. J. Med. Genet. Part. B: Neuropsychiatric Genet.141B (6), 643–647. 10.1002/ajmg.b.30391 (2006). [DOI] [PubMed] [Google Scholar]
- 11.Ravi, S. R. & Mendonca, T. L. Association of risk factors with At-Risk cases of autism. J. Health Allied Sci. NU. 14 (03), 346–354. 10.1055/s-0043-1774287 (2024). [Google Scholar]
- 12.Geier, D. A., Mumper, E., Gladfelter, B., Coleman, L. & Geier, M. R. Neurodevelopmental disorders, maternal Rh-negativity, and Rho (D) immune globulins: a multi-center assessment. Neuroendocrinol. Lett.29 (2), 272–280 (2008). [PubMed] [Google Scholar]
- 13.Ajdacic-Gross, V. et al. Relationship between ABO blood groups and mental disorders. J. Blood Med.16, 1–5. 10.2147/jbm.s470340 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.American College of Obstetricians and Gynecologists & ACOG. Practice bulletin 192: management of alloimmunization during pregnancy. Obstet. Gynecol.131 (3), e82–e90 (2018). [Available from: ACOG Practice Bulletin 192]. [DOI] [PubMed] [Google Scholar]
- 15.Croen, L. A., Matevia, M., Yoshida, C. K. & Grether, J. K. Maternal Rh D status, anti-D immune Globulin exposure during pregnancy, and risk of autism spectrum disorders. Am. J. Obstet. Gynecol.199 (3), 234e1–234e6. 10.1016/j.ajog.2008.04.044 (2008). [DOI] [PubMed] [Google Scholar]
- 16.Hollowood-Jones, K. et al. Altered metabolism of mothers of young children with autism spectrum disorder: a case control study. BMC Pediatr.20 (1), 557. 10.1186/s12887-020-02437-7 (2020). [Available from: Hollowood-Joneset al. 2020]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Elfeituri, M. A., Asaeti, Z. A., Elgazal, N. B., El-Amari, M. & Al-Ojali, S. M. Study of possible association between ABO blood groups and autism spectrum disorder. Scholars J. Appl. Med. Sci.10 (9), 1448–1456. 10.36347/sjams.2022.v10i09.006 (2022). [Google Scholar]
- 18.Little, R. J. & Rubin, D. B. Statistical Analysis with Missing Data (2nd ed.). Wiley Series in Probability and Statistics. John Wiley & Sons; (2002).
- 19.IBM Corp. IBM SPSS Statistics for Windows, Version 26.0. (2019).
- 20.Cleveland Clinic. Blood Types: Overview - What are blood types? (2023). https://my.clevelandclinic.org/health/treatments/21213-blood-types Accessed August, 13th 2024.
- 21.American Red Cross. Facts About Blood and Blood Types. (2024). https://www.redcrossblood.org/donate-blood/blood-types.html?icid=rdrt-blood-types&imed=direct&isource=drupal Accessed August, 13th 2024.
- 22.NHS. Blood groups. (2016). https://www.nhs.uk/conditions/blood-groups/ Accessed Februart 23rd, 2025 2025.
- 23.Estes, M. L. & McAllister, A. K. Maternal immune activation: implications for neuropsychiatric disorders. Science353 (6301), 772–777. 10.1126/science.aag3194 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Careaga, M., Rogers, S., Hansen, R. L., Van de Amaral, D. G. & Ashwood, P. Immune endophenotypes in children with autism spectrum disorder. Biol. Psychiatry. 81 (5), 434–441. 10.1016/j.biopsych.2015.08.036 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Cooling, L. Blood groups in infection and host susceptibility. Clin. Microbiol. Rev.28 (3), 801–870. 10.1128/cmr.00109-14 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Franchini, M. & Mannucci, P. M. ABO blood group and thrombotic vascular disease. Thromb. Haemost. 112 (12), 1103–1109. 10.1160/th14-05-0457 (2014). [DOI] [PubMed] [Google Scholar]
- 27.Grether, J. K., Anderson, M. C., Croen, L. A., Smith, D. & Windham, G. C. Risk of autism and increasing maternal and paternal age in a large North American population. Am. J. Epidemiol.170 (9), 1118–1126. 10.1093/aje/kwp247 (2009). [DOI] [PubMed] [Google Scholar]
- 28.Maimburg, R. D. & Væth, M. Perinatal risk factors and infantile autism. Acta Psychiatry. Scand.114 (4), 257–264. 10.1111/j.1600-0447.2006.00805.x (2006). [DOI] [PubMed] [Google Scholar]
- 29.Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R. & Van De Pessah, I. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain. Behav. Immun.25 (1), 40–45. 10.1016/j.bbi.2010.08.003 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Vasan, S. K. et al. ABO blood group and risk of thromboembolic and arterial disease. Circulation133 (15), 1449–1457. 10.1161/circulationaha.115.017563 (2016). [DOI] [PubMed] [Google Scholar]
- 31.Miles, J. H. & Takahashi, T. N. Lack of association between Rh status, Rh immune Globulin in pregnancy and autism. Am. J. Med. Genet. Part. A. 143 (13), 1397–1407. 10.1002/ajmg.a.31846 (2007). [DOI] [PubMed] [Google Scholar]
- 32.Smalley, S. L., Asarnow, R. F. & Spence, M. A. Autism and genetics: A decade of research. Arch. Gen. Psychiatry. 45 (10), 953–961. 10.1001/archpsyc.1988.01800340081013 (1988). [DOI] [PubMed] [Google Scholar]
- 33.Dean, L. Blood Groups and Red Cell Antigens (National Center for Biotechnology Information NCBI Bethesda, 2005). [Google Scholar]
- 34.Lehmann, H. The distribution of the human blood groups and other polymorphisms. Br. Med. J.1 (6023), 1472 (1976). Second ed. [Google Scholar]
- 35.Yamamoto, F., Cid, E., Yamamoto, M. & Blancher, A. ABO research in the modern era of genomics. Transfus. Med. Rev.28 (2), 103–118. 10.1016/j.tmrv.2011.08.002 (2014). [DOI] [PubMed] [Google Scholar]
- 36.Flegel, W. A. The genetics of the rhesus blood group system. Blood Transfus.5 (1), 50–57. 10.2450/2007.0011-07 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Availability of Data and Materials: The data supporting the findings of this study are included in the article and its supplementary materials. Raw data generated during the study are available upon reasonable request from the corresponding author.








